Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.
University of Illinois at Urbana-Champaign, Champaign, IL, USA.
Assessment. 2022 Jun;29(4):686-699. doi: 10.1177/1073191120986622. Epub 2021 Feb 1.
This study evaluated the psychometric properties and factor structure of the Calgary Depression Scale for Schizophrenia (CDSS) across different levels of the schizotypy continuum. A combined sample of high-schizotypy, at-risk mental states, and patients with first-episode psychosis was assessed for depression and other clinical and functional outcomes. Additionally, experience sampling methodology was used to assess depressive and psychotic-like experiences in daily life. The CDSS exhibited solid internal consistency, validity, and discrimination between depressed and nondepressed participants. Confirmatory factor analyses and the associations of the resulting factors with clinical and functional measures supported a two-factor structure that included general depression and guilt factors. Furthermore, both factors of the CDSS were differentially related to positive and negative symptoms of psychosis in daily life. The CDSS appears to have two underlying psychopathological dimensions and to be a reliable and valid measure for assessing depression across the schizotypy continuum.
本研究评估了 Calgary 精神分裂症抑郁量表 (CDSS) 在不同程度精神分裂症倾向连续体上的心理测量特性和因子结构。对高精神分裂症倾向、有风险的精神状态和首发精神病患者进行了抑郁和其他临床及功能结局评估。此外,还使用经验采样方法评估了日常生活中的抑郁和类精神病体验。CDSS 表现出良好的内部一致性、有效性和抑郁与非抑郁参与者之间的区分度。验证性因子分析以及由此产生的因子与临床和功能测量的关联支持了包含一般抑郁和内疚因子的两因素结构。此外,CDSS 的两个因子与日常生活中的精神病阳性和阴性症状均有不同程度的关系。CDSS 似乎具有两个潜在的精神病理学维度,是一种可靠和有效的评估精神分裂症倾向连续体上抑郁的测量工具。